Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Weekly Recap: Paper gains for a paper packaging producer
Analyst IPO Market Commentary
Pricing pressure continued this week as only one company was able to price in or above its range.
Five IPOs raised $1.2 billion this week, including one of the most highly-anticipated IPOs of 2015. However, it was a global print packaging manufacturer that had the best IPO. Two biotechs and a REIT specializing in farmland went public this week as well. One company failed to price for the
in a row, and six more filed, increasing the total to 30 filings in October.
Ferrari in pole position
Considered a bellwether for the fall IPO market,
) raised $893 million Tuesday in one of the most highly-anticipated IPOs of the year. It priced 17.2 million shares 4% above the midpoint at $52, then opened at $60. It was announced on Friday that Ferrari’s underwriters had exercised in full the option to buy additional shares, increasing the total IPO size to 18.9 million shares, for total gross proceeds of $982 million. The company has one of the world’s strongest brands, marketing the name through a storied racing legacy and cars that have attained almost legendary status. Manchester United, which has similarly intense brand support, is up 29% from its 2012 IPO price despite falling far short of expectations on earnings. Ferrari ended the week at $56.38, a gain of 8%.
The complete package
Multi Packaging Solutions
) had the best IPO of the week, popping 22% in its debut. In fact, the global print-based specialty packaging company had the best first day of all companies outside of the health care sector in the last three months. However, to get the deal done, the company priced shares 19% below the range at $13, and private equity backers Madison Dearborn and the Carlyle Group opted out of selling their shares on the offering. It did offer 3 million additional shares for a total of 16.5 million, so net proceeds were essentially the same (~$180 million). The company traded flat after the first day, closing Friday up 22%.
Biotechs are going to the dogs
Although it priced below the range,
) evidently did not price low enough as shares fell 17% on its first day. The company raised $72 million, coming to market at below the midpoint at $13. Despite decades of research on viral delivery gene therapies at the University of Pennsylvania, the market opportunity for lead product candidate DTX101 remains unclear as no gene therapies have been approved in the US.
), which is developing formulations of widely-used cancer drugs for humans and dogs, finally priced its IPO. It targeted a mid-September IPO, only to push it back multiple times before pricing at $4.06, 40% below its original midpoint, raising just $9 million. Including Dimension and Oasmia, the last 13 health care IPOs have averaged a total return of just 0.4%, with 10 pricing below the range.
Sell the farm
American Farmland Company
), a REIT with a focus on farmland in California, Illinois and Florida, raised $48 million by offering 6 million shares at $8. The company originally planned to offer 12 million shares at a range of $8.50 to $10.50 but it decreased its proposed deal size by 58% to get the deal done. It fell 13% in its debut, recovering slightly to end the week down 6%.
) failed to price for the second week in a row. The company, a fabless provider of flash memory chips for Internet of Things devices, is currently listed as day-to-day and hopes to raise $42 million.
5 IPOs during the week of October 19, 2015
Deal size ($mm)
IPO price vs. midpoint
Return at 10/23
Multi Packaging Solutions (
Paper packaging manufacturer
Luxury sports car manufactuer
Oasmia Pharmaceutical (
Biotech: cancer drugs for dogs and humans
Dimension Therapeutics (
Biotech: gene therapy for rare liver diseases
American Farmland Company (
REIT with farmland in CA, FL, and IL
IPO Market Snapshot
$28 billion has been raised so far in 2015, but just 37% of 2015 IPOs are trading above issue. An average first day pop of 15% has fallen to average returns of -5%. The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is down 7% year-to-date, compared to 1% for the S&P 500. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Twitter (
) and Hilton Worldwide (
). The Renaissance International IPO Index is down 1% year-to-date, compared to -1% for the ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Samsung C+T.
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.